viggoVet, the veterinary AI company built by veterinary-business founders and domain experts, has announced the relocation of its global headquarters to San Francisco. The move positions the company at the heart of the global technology ecosystem as it introduces VetEvince, the world’s first evidence-based veterinary AI, which debuted at the London Vet Show 2025 on November 20 and 21 at ExCeL London.
The headquarters transition marks a strategic expansion into the U.S. market, one of the fastest-growing regions for veterinary technology and innovation. Founded by Michael Gerges, viggoVet’s mission is to build AI systems rooted in authenticity, scientific rigor, and domain expertise. Unlike general-purpose AI tools, VetEvince has been created “by vets, for vets,” representing a lean, expert-driven business model designed around real-world veterinary practice rather than consumer-scale data approaches.
“VetEvince is the vet AI assistant grounded in evidence-based veterinary medicine, developed by veterinarians and data scientists who understand the realities of clinical decision-making,” said Gerges. “Our goal is not to replace veterinary judgment, but to reinforce it with trusted references, data lineage, and clinical context that support informed care.”
The evidence-based model is viggoVet’s defining advantage. VetEvince has been trained on peer-reviewed veterinary literature, clinical studies, and practice-level data to ensure each AI-generated recommendation includes verifiable sources. This transparency separates VetEvince from the black box models often found in consumer AI — placing trust, safety, and accountability at the core of every response.
Built within viggoVet’s integrated cloud platform, which already supports clinic management and business intelligence tools, VetEvince serves as a dedicated clinical AI module. Its design allows for seamless workflow integration, helping veterinary teams gain rapid, referenced insights while maintaining data privacy and security. The platform operates in encrypted, clinic-specific environments ensuring that sensitive data remains private and is never used to train external systems.
At the London Vet Show, viggoVet showcased VetEvince through live demonstrations that highlight how its evidence-based approach transforms the way clinical teams interact with AI. The company will also provide visuals and interface screenshots from VetEvince, showing how each answer is backed by scientific citations and reference trails that reflect the platform’s transparent, data-driven framework.
Gerges added, “This launch represents a proof point that deep domain expertise can outperform brute-force scale. By building AI with veterinary professionals from the ground up, we’re demonstrating a sustainable and efficient model for innovation that prioritizes accuracy, trust, and care quality.”
With operations in the U.S., viggoVet plans to expand its reach across other regions partnering with veterinary practices that value scientific integrity and efficiency. Through VetEvince, the company aims to redefine how veterinarians apply AI in daily clinical settings, anchored by evidence, shaped by experts, and built for global impact.
For further information, visit viggo.vet.
About viggoVet
viggoVet is a Swiss-founded veterinary technology company now headquartered in San Francisco, California. Built by veterinarians and business founders with deep domain expertise, viggoVet develops evidence-based AI solutions designed to enhance clinical decision-making and operational efficiency in veterinary practice. Its flagship innovation, VetEvince, is the world’s first evidence-based veterinary AI, a system that provides referenced, transparent, and trustworthy insights rooted in veterinary science. Combining Swiss precision, U.S. innovation, and a “by vets, for vets” philosophy, viggoVet is redefining how artificial intelligence serves animal health professionals worldwide. For more information, visit viggo.vet.
Media Contact
Michael Gerges
michael@viggo.vet
